CALC Conference

CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Published September 02, 2025 at 11:00 AM

(NASDAQ:CALC) LA JOLLA, Calif., Sept. 2, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory...